Michael SmedleyCardio Pharma CorpCOM.TOBUYSep 30, 2003

(A Top Pick Nov 20/06. Down 27%.) Has a nice little product and they are going through their trials and there is the talk of being a takeout. However, the market just doesn't care. Sold his holdings.

There were concerns on FDA approval, but he feels these are not major and the drug is good. Expect it will be taken over.

Have some excellent drugs. Data is coming out which they hope will be very good in the next 3/6 months.

Had some interesting trial data. Shares have moved up quite nicely, but now priced with good news built-in. Fully valued.